Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
View/ Open
Volume
7
Pagination
44505 - 44521
DOI
10.18632/oncotarget.9887
Journal
ONCOTARGET
Issue
ISSN
1949-2553